2022. Neoadjuvant and adjuvant immunotherapy for non-small cell lung cancer (literature review). Voprosy onkologii. 68, 2 (May 2022), 159–168. DOI:https://doi.org/10.37469/0507-3758-2022-68-2-159-168.